Cargando…
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
Background and Objectives: Fetal growth restriction (FGR) is associated with fetal mortality and is a risk factor for cerebral palsy and future lifestyle-related diseases. Despite extensive research, no effective treatment strategy is available for FGR. Mammalian target of rapamycin (mTOR) signaling...
Autores principales: | Tsuchiya, Kyoka, Tanaka, Kayo, Tanaka, Hiroaki, Maki, Shintaro, Enomoto, Naosuke, Takakura, Sho, Nii, Masafumi, Toriyabe, Kuniaki, Katsuragi, Shinji, Ikeda, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767347/ https://www.ncbi.nlm.nih.gov/pubmed/33371356 http://dx.doi.org/10.3390/medicina56120722 |
Ejemplares similares
-
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
por: Tanaka, Hiroaki, et al.
Publicado: (2019) -
Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022) -
Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling
por: Tanaka, Kayo, et al.
Publicado: (2022) -
Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
por: Maki, Shintaro, et al.
Publicado: (2020) -
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
por: Tsuji, Makoto, et al.
Publicado: (2023)